New technology has the potential to replace current 2D imaging such as MRI scans.

A new type of microscope can take 3D images of cells while working in a natural environment.

Improved method enables high-resolution chemical and structural imaging of cells at the nanoscale.

Optical coherence tomography is tested to evaluate transplant viability of donor organs.

New technology could enable point-of-care skin cancer diagnosis.

New kind of label-free deep-tissue imaging retrieves the fine neural network of a mouse brain.

A frequency-domain method possesses great potential to improve STED microscopy.

Leica Microsystems has introduced a new generation of its multiplexed imaging solution, Cell DIVE, including software and hardware improvements.